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Abstract  
 
  Polyhedral heteroboranes in particular dicarba-closo-dodecaboranes(12) and their 
organic derivatives have been the subject of intense research for over 40 years due to their 
unique chemical and physical properties. The initial attraction to dicarba-closo-
dodecaboranes(12) In the medicinal chemistry research, was a result of their high boron 
content and stability to catabolism, which are important criteria for cancer therapy, such as 
BNCT (boron neutron capture therapy) agents. The coordination compounds of the platinum 
group metals have also received large interest for their potential application as 
chemotherapeutic agents, since cis-diamminedichloroplatinum(II), cisplatin, has been reported 
to have  capability as tumor inhibitor. Hence, applications can be envisioned for related cis 
platinum complexes. Complex of cis-rac-[PtCl2{1,2-(PRCl)2C2B10H10}] (R=Ph, tBu, NEt2, NPh2) 
have been synthesized by employing known carbaborane based phosphine ligands of 
clorophoshino-closo-dodecaborane , with complex of cis-[PtCl2(COD)] (COD = 1,5-
cyclooctadiene) in an N2-atmosphere. The obtained complexes possess expected structure 
configuration, namely cis-rac. The characterization of the complex has been carried out using 
1H, 31P, 13C and 11B-NMR (Nuclear Magnetic Resonance), X-ray of single crystals, elemental 
analysis, IR (infra red) and mass spectroscopy (MS). The 31P{1H} NMR spectra of all the 
platinum complexes distinctly show the typical platinum satellites which are attributed to 31P-
195Pt-coupling, in which the 31P{1H} NMR spectrum exhibits three lines with an intensity ratio of 
ca. 1:4:1. The structure of the platinum complexes consists of a slightly distorted square-planar 
coordination sphere, in which the platinum atom is bonded to two chlorides and two 
phosphorus atoms of the chelating carbaboranylphosphine. Thus the platinum atoms exhibit 
the coordination number four, which is preferred in platinum(II) complexes. 
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INTRODUCTION 
 
Polyhedral heteroboranes in particular 
dicarba-closo-dodecaboranes(12) and their organic 
derivatives have been the subject of intense 
research for over 40 years due to their unique 
chemical and physical properties [Valliant, et al.,  
2002; Williams, 1992; Leites, 1992]. Thus, these 
compounds have been employed as catalysts 
[Yinghuai, et al., 2004; Larsen, et al., 2000; 
Teixidor, et al., 1996; Longato and  Bresadola, 
1982], as doping reagents in semiconductor 
materials [Bakun, et al., USSR Patent, 402241], 
and also in medical areas [Hawthorne, 1993; 
Soloway, 1998]. In the medicinal chemistry 
research, the initial attraction to dicarba-closo-
dodecaboranes(12) was a result of their high boron 
content and stability to catabolism, which are 
important criteria for BNCT (boron neutron 
capture therapy) agents. BNCT is based on the 
10
B(n, )
7
Li reaction, which occurs when boron-
10, which has a large capture cross section relative 
to the more abundant endogenous nuclei (
1
H, 
12
C, 
31
P, 
14
N), is exposed to thermal neutrons. The 
reaction releases high linear-energy-transfer 
radiation particles consisting of α-particles (
4
He) 
and lithium atoms (
7
Li)
 
[Locher, 1936]. These 
particles cause direct DNA damage and tumor cell 
death. 
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The coordination compounds of the 
platinum group metals have also received large 
interest for their potential application as 
chemotherapeutic agents, since cis-
diamminedichloroplatinum (II), cisplatin [Peyrone, 
M., 1844], has been reported to have capability as 
tumor inhibitor [Rosenberg, et al., 1969]. Cisplatin 
is one of the most commonly used anti-cancer 
drugs today. It is used mainly in combination 
chemotherapy and effective against testicular 
carcinomas [Rozencweig, et al., 1987]. The 
excellent activity of cisplatin in testicular 
carcinomas has demonstrated the possibility to find 
new drugs in the area of inorganic chemistry that 
are capable of curing specific types of tumors. 
Numerous other metal compounds containing 
platinum, other platinum group metals, and even 
non-platinum metals were then shown to be 
effective against human tumors and tumors in 
animals [Kopf-Maier, 1994]. Hence, applications 
can be envisioned for related 
carbaboranylphosphines and transition metal 
complexes thereof. 
In connection with our interest, related to 
the above mentioned areas, this paper describes the 
synthesis and the coordination properties of 
bidentate chiral tertiary phosphinodicarba-closo-
dodecaborane(12) ligands to form cis-platinum 
complexes. A range of ligands with different 
electronic and steric properties was synthesized by 
varying the substituents on the phosphorus atoms. 
Variation of these substituents can give significant 
changes in the electron-donor or -acceptor 
properties of the phosphines and in the steric 
demand of the phosphines as well. The resulting 
phosphines were employed as ligands in 
complexes of platinum metal.  
 
METHODS 
 
All the reactions were carried out in an 
atmosphere of dry nitrogen using standard Schlenk 
or vacuum line techniques. The solvents were 
purified (diethyl ether, THF, toluene: reflux over 
Na/benzophenone; CH2Cl2, n-hexane, MeOH: 
reflux over powdered CaH2) and distilled under 
nitrogen. The glassware was oven-dried for several 
hours, assembled while hot, and cooled in a stream 
of dry nitrogen gas. The infrared spectra were 
recorded on a Perkin-Elmer System 2000 FT-IR 
spectrometer scanning between 400 and 4000 cm
-1 
using KBr disks. The 
1
H, 
13
C, 
31
P and 
11
B NMR 
spectra were recorded on an AVANCE DRX 400 
spectrometer (Bruker). The chemical shifts for the 
1
H and 
13
C NMR spectra are reported in parts per 
million (ppm) at 400.13 MHz and 100.6 MHz with 
tetramethylsilane as standard. The chemical shifts 
for the 
31
P NMR spectra are reported in parts per 
million (ppm) at 161.97 MHz (with 85 % H3PO4 
external standard) and chemical shifts for 
11
B 
NMR spectra are in parts per million (ppm) at 
128.38 MHz with BF3 (OEt2) as external standard. 
The mass spectra were recorded on an Ltd. ZAB-
HSQ-VG Analytical Manchester Spectrometer 
(FAB mass spectra) and on an FT-ICR-MS 
Bruker-Daltonics ESI mass spectrometer (APEX 
II, 7 Tesla). The elemental analyses were recorded 
on a VARIO EL (Heraeus). The melting points 
were determined in sealed capillaries and are 
uncorrected. The products of the catalytic reactions 
were determined by GC analysis using an 
AGILENT 6890 gas chromatograph with 
split/splitless injector and a CP-CHIRASIL-L-
VAL column. The crystallographic data were 
collected on a Siemens CCD (SMART) 
diffractometer (compounds 5 and 6) and a Stoe-
IPDS imaging plate diffractometer (compound 7). 
The empirical absorption correction was 
performed with SADABS [Sheldrick, 1998] 
(Siemens CCD diffractometer) and the numerical 
absorption correction using XRED (Stoe-IPDS 
diffractometer). The structures were solved by 
direct methods (SHELXTL PLUS) [SHELXTL 
PLUS, SHELXS, 1990]. 
The compound ortho-closo-carbaborane 
was donated by INEOS (A. N. Nesmeyanov 
Institute of Organoelement Compounds Russian 
Academy of Sciences, Moscow, Russian 
Federation). The chemicals n-butyllithium, 
dichlorophenylphosphine, PCl3, N,N-diethylamin, 
tert-butylchlorid, N,N-diphenylamin, COD (1,5-
cyclooctadiene) were used as purchased. H2[PtCl6] 
· 6 H2O was generously donated by Umicore.  
t
BuPCl2 [Imori, 1992], P(NEt2)Cl2 [Perich 
and Johns, 1988], P(NPh2)Cl2 [Falius and Babin, 
1976],  [PtCl2(COD)] [Cotton, 1972; Brauer, G., 
1981],  were prepared according to the literature. 
 
Preparation of the Known Compounds   
rac-1,2-Bis(tert-butylchlorophosphino)-1,2-
dicarba-closo-dodecaborane(12) (1) [Sterzik et al., 
2001],  rac-1,2-bis(phenylchlorophosphino)-1,2-
dicarba-closo-dodecaborane(12) (2) [Balema et al., 
1999; Alexander and Schroeder, 1963],  rac-1,2-
Bis(N,N-diethylaminochlorophosphino)-1,2-
dicarba-closo-dodecaborane(12) (3), and rac-1,2-
Bis(N,N-diphenylaminochlorophosphino)-1,2-
dicarba-closo-dodecaborane(12) (4) [Stadlbauer  et 
al., 2009] were prepared according to the literature 
and obtained in good yield. 
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Synthesis of cis-rac-PtCl21,2-
(PtBuCl)2C2B10H10 (5)  
A mixture of 0.2 g (0.53 mmol) 
PtCl2(COD) (COD = 1,5-cyclooctadiene), 0.21 g 
(0.53 mmol) 1 and 50 ml toluene was refluxed for 
2 h. The mixture was then concentrated to yield a 
white precipitate (0.25 g). Crystallization from 
toluene solution gave colorless crystals of 5. Yield: 
0.25 g (73 %). M.p.: 280 C (decomposes, turns 
brown). Found: C 18.70; H 4.47 %. Calc. for 
C10H28B10Cl4P2Pt: C 18.83; H 4.31 %. FAB-MS, 
m/z: 619 (6 %, M
+
- Cl), 584 (2 %, M
+
- 2Cl). Calc. 
for C10H28B10Cl4P2Pt: M = 655.25. 
1
H NMR 
(CDCl3/TMS, ppm): 3.75 - 1.93 (m, vbr, 10H, 
C2B10H10), 1.73 (d, 
3
JPH = 22 Hz, 18H, CH3). 
31
P 
NMR (CDCl3, ppm): 122.6 (
1
JPPt = 3873 Hz). 
13
C 
NMR (CDCl3/TMS, ppm): 85.1 (dt, 
2
JCPt = 102.6 
Hz, 
1
JPC = 28.1 Hz, Ccluster-P), 50.1 (m, 
2
JCPt = 54.0 
Hz, 
1
JPC = 40.1 Hz, 
3
JPC = 7.9 Hz, CMe3), 28.5 (q, 
1
JCH = 130.0 Hz, 
2
JPC = 4.5 Hz, CH3). 
11
B NMR 
(CDCl3, ppm): 0.83 (d, 
1
JBH = 151 Hz, 2B, 
C2B10H10), -3.08 (d, 
1
JBH = 154 Hz, 2B, C2B10H10), 
-9.44 (m, vbr, 6B, C2B10H10). IR (KBr, cm
-1
): 
3015m, 2995m, 2961m, 2926m, 2868m (CH); 
2678m, 2666s, 2639s, 2595s, 2576s, 2564s (BH); 
1955w, 1626w, 1471s, 1459s, 1433m, 1401s, 
1368s, 1261m, 1165s, 1070s, 1017s, 976w, 930m, 
902w, 884w, 835m, 797s, 772m, 749s, 733s, 
682w, 665m, 629s, 570s, 542s, 495s, 458m, 448m. 
Synthesis of cis-rac-PtCl21,2-
(PPhCl)2C2B10H10 (6) 
A mixture of 0.2 g (0.53 mmol) 
PtCl2(COD), 0.23 g (0.53 mmol) 2 and 50 ml 
toluene was refluxed for 2 h. The mixture was then 
concentrated to yield 0.31 g of a white precipitate. 
Crystallization from toluene solution gave 
colorless crystals of 6. Yield: 0.31 g (83 %). M.p.: 
320 C (decomposes, turns brown). Found: C 
23.00; H 2.06 %. Calc. for C14H20B10Cl4P2Pt: C 
24.19; H 2.90 %. FAB-MS, m/z: 659 (100 %, M
+
- 
Cl), 624 (14 %, M
+
- 2Cl) 587 (11 %, M
+
 - 3Cl). 
Calc. for C14H20B10Cl4P2Pt: M = 695.25. 
1
H NMR 
(C6D6/TMS, ppm): 7.70 - 6.86 (m, 10H, Ph), 7.10 - 
6.90 (several m, Ph in C7H8), 3.73 - 1.01 (m, vbr, 
10H, C2B10H10), 2.10 (s, 3H, CH3 in C7H8). 
31
P 
NMR (C6D6, ppm): 97.8 (
1
JPPt = 4038 Hz). 
11
B 
NMR (C6D6, ppm): -1.8 (d, 
1
JBH = 143 Hz, 4B, 
C2B10H10), -10.2 (d, 
1
JBH = 142 Hz, 4B, C2B10H10), 
-13.6 (d, 
1
JBH = 168 Hz, 2B, C2B10H10). IR (KBr, 
cm
-1
): 3082w, 3055m, 3022m, 2959w, 2917w 
(CH); 2614, 2582 (BH); 2191w, 1965w, 1894w, 
1809w (Ph); 1603w, 1580m, 1494m, 1475m, 
1436s, 1384w, 1336w, 1310s, 1283w, 1261m, 
1186m, 1160m, 1097s, 1076s, 1025m, 997m, 
981m, 937m, 900m, 852s, 798s, 732s, 713s, 695s, 
684s, 630s, 616s, 575s, 553s, 514s, 485s, 472s. 
The low solubility of 6 prevents 
measurement of the
 13
C NMR spectrum. 
 
Synthesis of cis-rac-PtCl21,2-
{P(NEt2)Cl}2C2B10H10 (7)  
A mixture of 0.14 g (0.37 mmol) 
PtCl2(COD), 0.16 g (0.37 mmol) 3 and 50 ml 
toluene was refluxed for 10 h. The mixture was 
then concentrated to obtain 0.18 g of a white 
precipitate. Crystallization from toluene solution 
gave colorless crystals of 7. Yield: 0.18 g (70 %). 
M.p.: 230 C (decomposes, turns black). Found: C 
19.7; H 4.43; N 3.43 %. Calc. for 
C10H30B10Cl4N2P2Pt · 0.5C7H8 : C 22.17; H 4.69; 
N 3.83 %. FAB-MS, m/z: 649 (100 %, M
+
- Cl), 
614 (81 %, M
+
- 2Cl), 577 (12 %, M
+
 - 3Cl), 542 (8 
%, M
+
 - 4Cl). Calc. for C10H30B10Cl4N2P2Pt: M = 
685.31. 
1
H NMR (CDCl3/TMS, ppm): 3.65 and 
3.42 (m, br, 8H, CH2), 3.55 - 1.63 (m, vbr, 10H, 
C2B10H10), 1.23 (t, 
3
JHH = 8 Hz, 12H, CH3). 
31
P 
NMR (CDCl3, ppm): 98.2 (
1
JPPt = 4663 Hz). 
13
C 
NMR (CDCl3/TMS, ppm): 129.1 - 124.5 (several 
m, C7H8), 90.8 (tt, 
1
JPC = 25.2 Hz, 
2
JPC = 25.2 Hz, 
2
JCPt = 168.8 Hz, Ccluster-P), 44.3 (m, vbr, CH2), 
21.5 (q, 
1
JCH = 138.5 Hz) 12.8 (q, 
1
JCH = 126.7 Hz, 
CH3). 
11
B NMR (CDCl3, ppm): -2.2 (d, 
1
JBH = 142 
Hz, 4B, C2B10H10), -10.2 (m, vbr, 4B, C2B10H10), -
14.0 (m, vbr, 2B, C2B10H10). IR (KBr, cm
-1
): 
2981s, 2937s, 2894s (CH); 2621s, 2582s (BH); 
1860w, 1706w, 1626w, 1494w, 1462m, 1444m, 
1382s, 1363m, 1343m, 1289m, 1262w, 1201s, 
1151s, 1100s, 1076s, 1057s, 1020s, 962s, 925w, 
847s, 799s, 760w, 740m, 688m, 671m, 628s, 579s, 
549s, 495s, 459m, 417w. 
Synthesis of cis-rac-PtCl21,2-
{P(NPh2)Cl}2C2B10H10 (8) 
A mixture of 0.13 g (0.35 mmol) 
PtCl2(COD), 0.21 g (0.35 mmol) 4 and 35 ml 
toluene was refluxed for 105 h. The mixture was 
then filtrated and concentrated to obtain 0.043 g of 
a white precipitate of 8. Yield: 0.043 g (14 %). 
1
H 
NMR (CDCl3/TMS, ppm): 7.76 - 7.26 (m, br, 20H, 
Ph), 3.56 - 1.53 (m, vbr, 10H, C2B10H10). 
31
P NMR 
(CDCl3, ppm): 94.6 (
1
JPPt = 4895 Hz). 
11
B NMR 
(CDCl3, ppm): -2.4 (m, vbr, 4B, C2B10H10), -11.2 
(m, vbr, 6B, C2B10H10). The amount of substance 
obtained was insufficient for other characterization 
methods. 
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RESULTS AND DISCUSSION  
  
The preparation of a platinum complex with 
a non-chiral carbaboranylphosphine ligand, cis-
[PtCl2{1,2-(P
i
Pr2)2-1,2-C2B10H10}] has been 
reported [Paavola et al., 2002], in which 
[PtCl2(COD)] (COD = 1,5-cyclooctadiene) was 
used as starting material. Several platinum 
complexes with unsymmetrical tertiary 
bisphosphines of ortho-carbaborane were prepared 
as well, i. e. cis-[PtCl2{1-PPh2-2- 
P(NMe2)2(C2B10H10)}], cis-[PtCl2{1-PPh2-2-
P(NMe2)F(C2B10H10)}], cis-[PtCl2{1-P(NMe2)F-2-
P(NMe2)2(C2B10H10)}], and cis-[PtCl2{1-PPh2-2-
PF2(C2B10H10)}] [Hill et al., 1983]. However, 
platinum complexes with two chiral 
carbaboranylphosphine ligands were not yet 
explored. 
Synthesis and Spectroscopic Properties of 
Platinum Complexes with 
Carbaboranylphosphine Ligands 
 The platinum complexes cis-rac-PtCl21,2-
(PRCl)2C2B10H10 (R = 
t
Bu (5), Ph (6), NEt2 (7), 
NPh2 (8) were synthesized employing a similar 
procedure as for cis-[PtCl2{1,2-(P
i
Pr2)2-1,2-
C2B10H10}], in which [PtCl2(COD)] was stirred in 
a boiling toluene solution with a suitable chiral 
carbaboranylphosphine ligand (1-4). 
Except cis-rac-PtCl21,2-
{P(NPh2)Cl}2C2B10H10 (8), all other platinum 
complexes were obtained in good yield (67-93 %). 
Complex 8 could only be obtained in 14 % yield. 
The signal of the free ligand was observed in the 
31
P NMR spectrum of the reaction mixture even 
after refluxing for more than 100 h, while the 
amount of the side products increased. The steric 
demand of the bulkier substituent, NPh2, is 
presumably responsible for hampering the 
complexation. Compounds 5 - 8 were obtained as 
air- and water-stable solids that are slightly soluble 
in organic solvents.  
 The 
31
P{
1
H} NMR spectra of all the 
platinum complexes distinctly show the typical 
platinum satellites which are attributed to 
31
P-
195
Pt-
coupling, in which the 
31
P{
1
H} NMR spectrum 
exhibits three lines with an intensity ratio of ca. 
1:4:1 [Berger et al., 1996]. The spectroscopic data, 
31
P{
1
H} chemical shifts and 
1
JPPt, for complexes 5 
- 8, are listed in Table 1.   
Complexes 5 and 6 exhibit the signal at 
122.6 and 97.8 ppm in the 
31
P NMR spectrum, 
respectively. These peaks are shifted by ca. 6 and 
18 ppm to lower field relative to the signal of the 
free ligands indicating the PPt donation of the 
P
t
BuCl or PPhCl group. This effect was also 
observed for the platinum complexes of the related 
compounds, 
t
Bu2PC2H4P
t
Bu2
 
[Benn et al., 1986] 
and Ph2PC2H4PPh2 [Baldwin and Fink, 2002]. 
Complexes 7 and 8 have, however, chemical shifts 
at higher field by ca. 19 and 10 ppm compared 
with the signals of the free ligands, 117.2 (3) and 
104.3 ppm (4), respectively. 
This effect reflects the increase in electron 
density at the phosphorus atoms, which is 
presumably due to the p(N)-d(P) interaction. 
This also affects the phosphorus-platinum donor 
bond as well as the platinum-phosphorus 
backbonding, which is expected to increase as the 
electronegativity of the substituents at phosphorus 
increases [Hill et al., 1983].  
The large 
1
JPPt values of the complexes 
(3873 - 4895 Hz) indicate the cis coordination of 
the bidentate phosphine ligands [Berger et al., 
1996; Sturm et al., 2000; Gray et al., 2000], as 
shown also by the X-ray structures, whereas the 
1
JPPt values for trans platinum complexes are 
significantly lower [Berger et al., 1996; Johansson,  
et al., 2001]. While the tert-butyl groups in 
complex 5 cause the smallest P-Pt coupling 
constant, the diphenylamino groups in complex 8 
are responsible for the largest P-Pt coupling 
constant. In general, the P-Pt coupling constants of 
the complexes increase with the electronegativity 
of the substituents on phosphorus, which increases 
the -acceptor character of the phosphines [Hill et 
al., 1983; Grim et al., 1967]. 
In the 
13
C NMR spectra, complexes 7 
exhibits the complex coupling patterns of an 
AA’XX’ spin system for the PCCP group, which 
appears as a pseudo-triplet, in which the coupling 
constants, 
1
JPC  
2
JPC, is 25.2 Hz. While a more 
complex pattern is observed for complex 5 due to 
coupling to the platinum and phosphorus atoms 
(
2
JPtC = 102.6 Hz; 
1
JPC = 28.1 Hz). Complex 6 is 
very little soluble in conventional organic solvents, 
therefore no 
13
C NMR spectra could be obtained. 
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Table 1.   31P{1H} chemical shifts, 1JPPt of complexes 5-8 and the chemical shift differences between the 
complexes and the free ligand (complex - ligand) 
Complex 31P{1H} 
(ppm) 
1JPPt 
(Hz) 
Δ (ppm) 
cis-rac-PtCl21,2-(PtBuCl)2C2B10H10 (5) 122.6 3873 6 
cis-rac-PtCl21,2-(PPhCl)2C2B10H10 (6) 97.8 4038 18 
cis-rac-PtCl21,2-(P{NEt2}Cl)2C2B10H10 (7) 98.2 4663 -19 
cis-rac-PtCl21,2-(P{NPh2}Cl)2C2B10H10 (8) 94.6 4895 -10 
  
Table II.  Selected bond lengths (Å) of 5 and 6 
5 6 
Pt(1)-P(2) 2.208(9) Pt(1)-P(2) 2.193(9) 
Pt(1)-P(1) 2.217(8) Pt(1)-P(1) 2.203(9) 
Pt(1)-Cl(4) 2.324(9) Pt(1)-Cl(3) 2.328(1) 
Pt(1)-Cl(3) 2.334(9) Pt(1)-Cl(4) 2.328(9) 
Cl(1)-P(1) 2.020(1) Cl(1)-P(1) 2.007(1) 
Cl(2)-P(2) 2.008(1) Cl(2)-P(2) 2.009(1) 
P(1)-C(3) 1.875(3) P(1)-C(3) 1.798(4) 
P(1)-C(1) 1.890(3) P(1)-C(1) 1.861(4) 
P(2)-C(2) 1.878(3) P(2)-C(9) 1.796(4) 
P(2)-C(7) 1.881(3) P(2)-C(2) 1.857(4) 
C(1)-C(2) 1.708(4) C(1)-C(2) 1.672(5) 
 
 
 
Pt
Cl4Cl3
C6
C5
C3
C4
Cl1
P1
C1
C2
C8
C9
C10C12
P2
 
Fig. 1. Molecular structure of 5 (ORTEP plot with atom labeling scheme, thermal ellipsoids are drawn 
at the 50 % probability level, hydrogen atoms are omitted for clarity, only one enantiomer is 
shown) 
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C1
C2
P1 P2
Cl1
Cl2
Pt
C3
C4
C5C6
C7
C8
C9
C10
C11
C12
C13
C14
Cl3Cl4
 
 
Fig. 2.   Molecular structure of 6 (ORTEP plot with atom labeling scheme, thermal ellipsoids are drawn at 
the 50 % probability level, hydrogen atoms are omitted for clarity, only one enantiomer is shown) 
 
Table III.  Selected bond angles (deg.) for 5 and 6 
5 6 
P(2)-Pt(1)-P(1) 93.2(3) P(2)-Pt(1)-P(1) 92.3(3) 
P(2)-Pt(1)-Cl(4) 89.5(3) P(2)-Pt(1)-Cl(3) 88.4(4) 
P(1)-Pt(1)-Cl(4) 166.8(3) P(1)-Pt(1)-Cl(3) 178.8(3) 
P(2)-Pt(1)-Cl(3) 165.1(3) P(2)-Pt(1)-Cl(4) 178.3(3) 
P(1)-Pt(1)-Cl(3) 93.0(3) P(1)-Pt(1)-Cl(4) 88.1(3) 
Cl(4)-Pt(1)-Cl(3) 87.6(3) Cl(3)-Pt(1)-Cl(4) 91.2(4) 
C(3)-P(1)-C(1) 107.6(1) C(3)-P(1)-C(1) 108.4(2) 
C(3)-P(1)-Cl(1) 102.4(1) C(3)-P(1)-Cl(1) 104.5(1) 
C(1)-P(1)-Cl(1) 103.6(1) C(1)-P(1)-Cl(1) 101.6(1) 
C(3)-P(1)-Pt(1) 119.7(1) C(3)-P(1)-Pt(1) 117.6(1) 
C(1)-P(1)-Pt(1) 108.8(1) C(1)-P(1)-Pt(1) 109.8(1) 
Cl(1)-P(1)-Pt(1) 113.5(4) Cl(1)-P(1)-Pt(1) 113.6(5) 
C(2)-P(2)-C(7) 110.3(1) C(9)-P(2)-C(2) 104.8(2) 
C(2)-P(2)-Cl(2) 102.8(1) C(9)-P(2)-Cl(2) 105.1(1) 
C(7)-P(2)-Cl(2) 102.0(1) C(2)-P(2)-Cl(2) 103.2(1) 
C(2)-P(2)-Pt(1) 109.8(1) C(9)-P(2)-Pt(1) 120.3(1) 
C(7)-P(2)-Pt(1) 116.8(1) C(2)-P(2)-Pt(1) 109.9(1) 
Cl(2)-P(2)-Pt(1) 114.1(4) Cl(2)-P(2)-Pt(1) 112.2(5) 
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Table IV.  Selected bond lengths (Å) and bond angles (deg.) for 7 
Selected bond lengths Selected bond angles 
Pt(1)-P(2) 2.192(7) P(2)-Pt(1)-P(1) 92.3(2) 
Pt(1)-P(1) 2.202(6) P(2)-Pt(1)-Cl(3) 179.7(3) 
Pt(1)-Cl(3) 2.342(9) P(1)-Pt(1)-Cl(3) 87.4(3) 
Pt(1)-Cl(4) 2.344(6) P(2)-Pt(1)-Cl(4) 88.9(2) 
Cl(1)-P(1) 2.010(8) P(1)-Pt(1)-Cl(4) 177.0(2) 
Cl(2)-P(2) 2.013(8) Cl(3)-Pt(1)-Cl(4) 91.4(3) 
P(1)-N(1) 1.636(2) N(1)-P(1)-C(1) 108.6(1) 
P(1)-C(1) 1.879(2) N(1)-P(1)-Cl(1) 107.6(9) 
P(2)-N(2) 1.628(2) C(1)-P(1)-Cl(1) 100.2(7) 
P(2)-C(2) 1.877(2) N(1)-P(1)-Pt(1) 115.0(8) 
C(1)-C(2) 1.678(3) C(1)-P(1)-Pt(1) 110.2(8) 
  Cl(1)-P(1)-Pt(1) 114.1(3) 
  N(2)-P(2)-C(2) 107.6(1) 
  N(2)-P(2)-Cl(2) 106.0(9) 
  C(2)-P(2)-Cl(2) 100.9(7) 
  N(2)-P(2)-Pt(1) 118.3(8) 
  C(2)-P(2)-Pt(1) 109.9(8) 
  Cl(2)-P(2)-Pt(1) 112.8(4) 
    
 
 
 
 
 
 
 
 
 
P1
C1
C2
P2
Cl2
Cl1
Pt
Cl3 Cl4
N1
N2
C3
C4
C5
C6
C7
C8C9
C10
 
 
Fig. 3.  Molecular structure of 7 (ORTEP plot with atom labeling scheme, thermal ellipsoids are drawn 
at the 50 % probability level, hydrogen atoms are omitted for clarity, only one enantiomer is 
shown) 
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The carbon atoms of the carbaborane cluster 
in 7 also show coupling to the platinum atom (
2
JPtC 
= 169 Hz), whereas no coupling was observed in 
other platinum complexes. The platinum-carbon 
coupling was observed also for the tert-butyl group 
of compound 5 (
2
JPtC = 54 Hz).  
The chemical shift of the carbon atoms of 
the tert-butyl group in compound 10 is shifted 
downfield by ca. 10 ppm with respect to that in the 
free ligand 1 [Sterzik et al., 2001] and split into a 
triplet of pseudotriplets due to coupling with the 
platinum and phosphorus atoms (
1
JPC = 40.1 and 
3
JPC = 7.9 Hz), whereas in the free ligand the 
coupling constant is smaller (
1
JPC = 17 Hz).  
Single crystals of 5 and 6 were obtained 
from a concentrated toluene solution at room 
temperature. Compound 5 crystallizes in the 
orthorhombic space group Pbca with eight formula 
units in the unit cell, complex 6 crystallizes in the 
triclinic space group P1 with two molecules in the 
unit cell. Due to the crystallographic center of 
inversion, both enantiomers (R,R and S,S) are 
present in the unit cell of compound 5 and 6 (Fig. 1 
and Fig. 2). Selected bond lengths and angles of 5 
and 6 are reported in Table 2.  
 Colorless crystals of compounds 7 was 
obtained from a toluene solution at room 
temperature. Single crystals of 7 crystallizes in the 
triclinic space group P1, in which two molecules 
of 7 and one molecule of toluene were found in the 
unit cell of 7. Selected bond lengths and angles of 
7 are collected in Table 4. 
The structure of the platinum complexes 
consists of a slightly distorted square-planar 
coordination sphere, in which the platinum atom is 
bonded to two chlorides and two phosphorus 
atoms of the chelating carbaboranylphosphine. 
Thus the platinum atoms exhibit the coordination 
number four, which is preferred in platinum(II) 
complexes [Paavola et al., 2002; Hill et al., 1983; 
Cravotto et al., 2005; Hush et al., 2005]. The sums 
of the bond angles of platinum are around 360º. 
The coordination of the chelating 
carbaboranylphosphine ligands to platinum leads 
to the formation of a five-membered ring.  
 As expected, the P(1)-Pt-P(2) bond angles 
in the monomer platinum complexes are found 
between 92.3(3)º (6 and 7) and 93.2º (3) (5), which 
is the preferred P-M-P bite angle for square-planar 
complexes with two carbon atoms as spacer 
between the two phosphorus donor atoms [Van 
Leeuwen et al., 2000]. According to the 
Cambridge Crystallographic Data Center (CCDC) 
the P-Pt-P bond angles for related platinum 
complexes lie in the range of 82.4 [Vasconselos et 
al., 1998]
 
to 93.1º [Paavola et al., 2002]. Thus, 
compound 5 exhibits the largest P-Pt-P bond 
angle. 
 The Pt-P distances in 7 is 2.192(7) Å, which 
is in the range of Pt-P bond lengths for related 
compounds (2.182
 
Å
 
[Claver et al., 2000] - 2.278 
Å [Harada, 1976]). The short bond lengths indicate 
relative strong Pt-P bonds, which can be 
rationalized by the presence of the ortho-
carbaborane backbone as well as the electron-
withdrawing substituents on the phosphorus atoms. 
The Pt-Cl bonds in 5 is 2.324(9) Å, which is in 
agreement with those observed in related platinum 
complexes (2.327-2.395 Å [Dahlenburg and 
Mertel, 2001]). 
It has been reported previously, that the P-Pt 
coupling constants reflect the strength of the Pt-P 
bonds [Hill et al., 1983]. Therefore, compound 7, 
which possess the largest 
1
JPPt coupling constant, 
display the shortest Pt-P bonds. This trend is 
expected since the electron-withdrawing 
substituents on the phosphorus atoms increase the 
dd interaction between the platinum and the 
phosphorus donor atoms [Grim et al., 1967]. On 
the other hand, this so-called backbonding would 
also increase the -bond character of the Pt-P bond 
by a synergistic effect [Grim et al., 1967]. The 
backbonding effect is also revealed by the 
31
P 
NMR spectrum, in which the signals of the 
platinum complexes 7 - 8 are shifted to higher field 
relative to those of the free ligands. 
The C-C distances of the carbaborane cage 
were found to decrease on complexation to 
platinum. Compound 5 provides the largest 
decrease in C-C distance for the mononuclear 
platinum complexes, i.e. 0.062 Å relative to that of 
the free ligand 1 (1.770 Å) [Sterzik et al., 2001]. 
The diminution of C-C distances can be 
rationalized by the change of electronic properties 
of the phosphorus atoms due to complexation.  
It was observed that major elongation of the 
C-C bond is obtained when the element with the 
lone pair of electrons is directly connected with the 
cluster. The electron density from the available 
lone pair of electrons of the element is transferred 
to the cage, producing an increase in the C-C 
distance [Teixidor et al., 2003]. The electron 
density on the phosphorus atoms in 5 is lower due 
to the strong  (PPt) donor character of the 
P
t
BuCl group, resulting in a larger decrease in C-C 
bond length relative to the free ligand. 
A decrease in P-Ccluster bond lengths is also 
observed for the the platinum complexes, which is 
probably due to the change in electron density of 
the phosphorus atoms during the complexation. 
Compound 6 shows the largest decrease in the P-
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Ccluster distance of the mononuclear platinum 
complexes, which indicates a higher electron 
density on the phosphorus atoms.  
 
CONCLUSION  
 
Compounds 1, 2, 3, and 4 show the 
capability to act as ligands in complexation 
reactions with platinum metal. The platinum 
complexes cis-rac-PtCl21,2-(PRCl)2C2B10H10 
(R = 
t
Bu (5), Ph (6), NEt2 (7), NPh2 (8) were 
obtained from the reaction of [PtCl2(COD)] with 
the corresponding chiral carbaboranylphosphine 
ligand 1 – 4.  The complexes mentioned above 
were fully characterized by NMR, IR, and MS, 
and, other than 14 and 22, also by X-ray 
crystallography. 
 
ACKNOWLEDGMENT  
 
We gratefully acknowledge support from 
the Deutscher Akademischer Austausch Dienst 
(DAAD doctoral grant for I.M.). 
 
REFERENCES 
 
Alexander, R.P. and Schroeder, H.J., 1963, 
Chemistry of Decaborane-Phosphorus 
Compounds. IV. Monomeric, Oligomeric, 
and Cyclic phosphino-carboranesl, Inorg. 
Chem., 2, 1107. 
Balema, V.P., Blaurock, S. and Hey-Hawkins, E., 
1999, The reaction of phenylchloro 
phosphino substituted dicarba-closo-
dodecaboranes(12) with elemental sulfur 
and molecular structures of rac-bis-
phenylchlorophosphino dicarba-closo-
dodecaborane  and 
phenylchlorothiophosphino phenyldicarba-
closo-dodecaborane, Polyhedron, 18, 545. 
Bakun, A.V., Yu. P. Dokuchaev, I. I. Lapidis, Yu. V. 
Moskovskii, I. M. Skvortsov, B. G. Antokin, 
USSR Patent, 402241. 
Berger, S., Braun, S. and Kalinowski, H.-O., 1996, 
NMR-Spectroscopy of the Non-Metallic 
Elements, VCH Verlagsgesellschaft mbH, 
Weinheim. 
Benn, R., Jolly, P.W., Joswig, T., Maynott, R. And 
Schick, K.-P., 1986, Z. Naturforsch., 41b, 
680. 
Brauer, G., 1981, Handbuch der Präparativen 
Anorganischen Chemie, Band III,  Ferdinand 
Enke Verlag, Stuttgart. 
Claver, C., Fernandez, E., Gillon, A., Heslop, K., 
Hyett, D.J., Martorell, A., Orpen, A.G. and 
Pringle, P.G., 2000, Biarylphosphonites: a 
class of monodentate phosphorus(III) 
ligands that outperform their chelating 
analogues in asymmetric hydrogenation 
catalysis, Chem. Comm., 961. 
Cravotto, G., F. Demartin, G. Palmisano, A. 
Penoni, T. Radice, S. Tollari, 2005, Novel 
cyclometallated Pd(II) and Pt(II) complexes 
with indole derivatives and their use as 
catalysts in Heck reaction, J. Organomet. 
Chem., 690, 2017. 
Cotton, F.A., 1972, Inorg. Syn., 13, 48. 
Dahlenburg, L., S. Mertel, 2001, Chirale 
Bisphosphane VI. Chelatkomplexe von 
Platin(II) mit racemischen und optisch 
reinen trans-Cyclopentan-1,2-diyl-
bis(phosphonigsa¨urediester)- und trans-
Cyclopentan-1,2-diyl-
bis(phosphonigsa¨urediamid)-Liganden: 
Synthesen, Strukturen und C–H-
Aktivierungsreaktionen, J. Organomet. 
Chem., 630, 221Falius, H., M. Babin, 1976, 
Z. Anorg. Allg. Chem., 420, 65. 
Gray, G. M., D. C. Smith Jr., C. H. Duffey, 2000, 
31P{1H} NMR spectroscopic and X-ray 
crystallographic studies of conformational 
dynamics in cis-
M{Ph2P(CH2CH2O)5CH2CH2PPh2-P,P} 
(M_Mo(CO)4, PtCl2) metallacrown ethers, 
Inorg. Chem., 581, 300-302. 
Grim, S. O., R. L. Keiter, W. McFarlane, 1967, A 
Phosphorus-31 Nuclear Magnetic 
Resonance Study of Tertiary Phosphine 
Complexes of Platinum(1I), Inorg. Chem., 6, 
1133. 
Harada, M., Y. Kai, N. Yasuoka, N. Kasai, 1976, 
Bull. Chem. Soc. Japan., 49, 3472. 
Hawthorne, M.F., 1993, Angew. Chem. 105, 997. 
Hill, W. E., B. G. Rackley, L. Silva-Trivino, 1983, 
Inorg. Chem. Acta, 75, 51. 
Hush, N. S., J. Schamberger, G. B. Bacskay, 2005, 
A quantum chemical computational study 
of the relative stabilities of cis- and trans-
platinum dichloride in aqueous solution, 
Coord. Chem. Rev., 249, 299. 
Van Leeuwen, P. W. N. M., P. C. J. Kamer, J. N. H. 
Reek, P. Dierkes, 2000, Ligand Bite Angle 
Effects in Metal-catalyzed C-C Bond 
Formation, Chem. Rev., 100, 2741. 
Imori, T., T. Ninomiya, K. Konda, 1992, Jpn. Kokai 
Tokkyo Koho, 4. 
Johansson, M. H., T. Malmström, O. F. Wendt, 
2001, Chiral platinum(II) complexes. 
Crystal and molecular structures of cis-
[PtPhCl((R,R)-CHIRAPHOS)] and cis-
Maulana, et al., 2010 
Indones. J. Cancer Chemoprevent., 1(1), 1-11 
-4567- 
10 
 
[PtCl2((R,R)-CHIRAPHOS)] Inorg. Chim. 
Acta, 316, 149. 
Kopf-Maier, 1994, Complexes of metals other 
than platinum as antitumour agents, Eur. J. 
Clin. Pharmacol, 47, 1. 
Larsen, A. S., J. D. Holbrey, F. S. Tham, C. A. 
Reed, 2000, Designing Ionic Liquids: 
Imidazolium Melts with Inert Carborane 
Anions, J. Am. Chem. Soc., 122, 7264. 
Leites, L.A., 1992, Vibrational Spectroscopy of 
Carboranes and Parent Boranes and Its 
Capabilities in Carborane Chemistry, 
Chem. Rev., 92, 279. 
Locher, G.L., 1936, Am. J. Roentgenol. Radium Ther., 
36, 1. 
Longato, B. and Bresadola, S., 1982, Hydridoalkyl- 
and Hydridoalkenyliridium( 111) 
Complexes Formed in the Reaction of 
(Carboranyl)iridium(III) Dihydrides with 
Alkenes and Alkynes. 1, Inorg. Chem., 21, 
168. 
Paavola, S., Teixidor, F., Viñas, C. and Kivekäs, R., 
2002, Pd(II) bromide complexes of 1,2-
bis(diphenylphosphino)-1,2-dicarbacloso-
dodecaborane. Crystal structures of 
[PdBr2(1,2-(PPh2)2-1,2-C2B10H10)]CH2Cl2, 
[PdBr1.133Cl0.867(1,2-(PPh2)2-1,2-C2B10H10)] 
CH2Cl2 and [PdBrCl0.541Me0.459(1,2-(PPh2)2-
1,2-C2B10H10)]/CHCl3,  Acta Crystallogr., 
C58, m237. 
Peyrone, M., 1844, Annalen der Chemie und 
Pharmacie, Band LI, 1 ff. 
Perich, J.W. and Johns, R.B., 1988, Synthesis, 2, 142 
Rosenberg, B., VanCamp, L., Trosko, J.E. and 
Mansour, V.H., 1969, Nature, 222, 385. 
Rozencweig, M., von Hoff, D.D. and Slovik, M., 
1987, Cis-Diamminochloroplatinum, Ann. 
Intern. Med., 86, 803. 
SHELXTL PLUS, SHELXS, 1990, Program for 
Crystal Structure Solution, SHELXL, 
Program for Crystal Structure 
Determination, XP, Interactive Molecular 
Graphics, Siemens Analytical X-ray 
Institute Inc. 
Sheldrick, G.M., 1998, SADABS - Program for 
Empirical Absorption Correction, 
Göttingen. 
Soloway, A.H., Tjarks, W., Baruum, B.A., Rong, 
F.G., Barth, R.F., Codogni, I.M. and Wilson, 
J.G., 1998, The Chemistry of Neutron 
Capture Therapy, Chem. Rev., 98, 1515. 
Sterzik, A., Rys, E., Blaurock, S. and Hey-Hawkins, 
E., 2001, Synthesis and coordination 
properties of 1-tert-butylchlorophosphino- 
and 1,2-bis(tert-butylchlorophosphino)-1,2-
dicarba-closo-dodecaborane(12)—
molecular structures of rac and meso-1,2-
(PtBuCl)2C2B10H10 and (R,R,R,R/S,S,S,S)-
[{Cu{1,2-(PtBuCl)2C2B10H10}(Cl)}2], 
Polyhedron, 20, 3007. 
Stadlbauer, S., Frank, R., Maulana, I., Loennecke, 
P., Kirchner, B. and Hey-Hawkins, E., 2009, 
Synthesis and Reactivity of ortho-
Carbaborane-Containing Chiral 
Aminohalophosphines, Inorg. Chem., 48, 
6072-6082. 
Sturm, T., Weissensteiner, W., Mereiter, K. Kégl, 
T., Jeges, G., Petölz, G. and Kollár, L., 
2000, Platinum complexes of 
heteroannularly bridged heterobidentate 
ferrocenyl diphosphine ligands: their 
molecular structure and their use in 
catalytic carbonylation reactions, J. 
Organomet. Chem., 595, 93. 
Teixidor, F., Viñas, C., Demonceau, A. and Nuñez, 
R., 2003, Boron clusters: Do they receive 
the deserved interest?, Pure Appl. Chem., 
75, 1305. 
Teixidor, F., Flores, M.A., Viñas, C., Kivekäs, R. 
and Sillanpää, R., 1996, Rhodium 
Complexes with the New Anionic 
Diphosphine [7,8-(PPh2)2-7,8-C2B9H10]- 
Ligand, Angew. Chem. Int. Ed. Engl., 35, 
2251. 
Valliant, J.F., Guenther, K.J., King, A.S., Morel, P.  
Schaffer, P., Sogbein, O.O. and Stephenson, 
K.A., 2002, The medicinal chemistry of 
carboranes, Coord. Chem. Rev., 232, 173. 
Vasconselos, I.C.F., Anderson, G.K., Rath, N.P. 
and Spilling, C.D., 1998, Preparation and 
Structure of new homochiral 
diazaphosphol ligands and their platinum(II) 
chloride complexes, Tetrahedron: 
Asymmetry, 9, 927. 
Williams, R.E., 1992, The Polyborane, Carborane, 
Carbocation Continuum: Architectural 
Patterns, Chem. Rev., 92, 177. 
Yinghuai, Z., Parthiban, A. and Kooli, F.B.H.,  2004, 
Syntheses and catalytic properties of 
polystyrene supported nickel(II) carborane 
complexes, Catalysis Today, 96, 143. 
